| Literature DB >> 32748822 |
Mohammed Al Zobbi1, Belal Alsinglawi1, Omar Mubin1, Fady Alnajjar2.
Abstract
Coronavirus Disease 2019 (COVID-19) has affected day to day life and slowed down the global economy. Most countries are enforcing strict quarantine to control the havoc of this highly contagious disease. Since the outbreak of COVID-19, many data analyses have been done to provide close support to decision-makers. We propose a method comprising data analytics and machine learning classification for evaluating the effectiveness of lockdown regulations. Lockdown regulations should be reviewed on a regular basis by governments, to enable reasonable control over the outbreak. The model aims to measure the efficiency of lockdown procedures for various countries. The model shows a direct correlation between lockdown procedures and the infection rate. Lockdown efficiency is measured by finding a correlation coefficient between lockdown attributes and the infection rate. The lockdown attributes include retail and recreation, grocery and pharmacy, parks, transit stations, workplaces, residential, and schools. Our results show that combining all the independent attributes in our study resulted in a higher correlation (0.68) to the dependent value Interquartile 3 (Q3). Mean Absolute Error (MAE) was found to be the least value when combining all attributes.Entities:
Keywords: COVID-19; basic reproduction number; government regulations; infectious disease modeling; machine learning; spread control
Mesh:
Year: 2020 PMID: 32748822 PMCID: PMC7432619 DOI: 10.3390/ijerph17155574
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Comparison between COVID-19, SARS, MERS, and EVD.
| Description | COVID-19 1 | SARS 2 | MERS 3 | EVD 4 |
|---|---|---|---|---|
| Incubation period | 2–14 days | 2–10 days | 2–14 days | 2–21 days |
| Contagious during incubation | Yes | Yes | Yes | No |
| Vaccine release year | N/A | N/A | N/A | Dec. 2019 |
| Infected body part | Blood vessels | Respiratory system | Respiratory system | All muscles |
| Latest outbreak | Dec. 2019 | Nov. 2002–July 2003 | April 2012 | Dec. 2013–June 2016 |
| July 2015 | ||||
| Winter/summer impact | Likely | Likely | Not likely | Not likely |
| Main transmission | Respiratory droplet secretions | Respiratory droplet secretions | Respiratory droplet secretions | Body fluids |
| Shape and size in nm | Spherical 80–120 nm | Spherical 80–90 nm | Spherical 90–125 nm | Filament |
| 14,000 × 80 nm | ||||
| Temperature impact | Likely | Likely | Likely | Likely |
| Mortality rate | 2.65% | 14–15% | 34% | Up to 90% |
| Pronounced R-naught | 2–2.5 | 3.1–4.2 | <1 | 1.5–1.9 |
1. COVID-19: Coronavirus Disease 2019; 2. SARS: Severe Acute Respiratory Syndrome; 3. MERS: Middle East respiratory syndrome; 4. EVD: Ebola Virus Disease.
Dataset abstracted from UNESCO [16] and Google reports [15].
| Country | Date | >Q3 1 | Retail and Recreation | Grocery/Pharmacy | Parks | Transit Stations | Workplaces | Residential | Schools |
|---|---|---|---|---|---|---|---|---|---|
| Australia | 3/20/20 | 0.22 | −12 | 20 | −12 | −22 | 0 | 6 | 0 |
| Australia | 3/21/20 | 0.25 | −17 | 11 | −9 | −28 | −4 | 7 | 0 |
| Australia | 3/22/20 | 0.26 | −18 | 10 | −11 | −34 | −12 | 6 | 0 |
| Australia | 3/23/20 | 0.25 | −17 | 17 | −27 | −36 | −6 | 8 | 0 |
| Australia | 3/24/20 | 0.25 | −30 | 4 | −30 | −45 | −19 | 12 | −30 |
| Australia | 3/25/20 | 0.25 | −31 | 2 | −33 | −50 | −23 | 14 | −30 |
| Australia | 3/26/20 | 0.25 | −34 | 2 | −23 | −53 | −27 | 16 | −30 |
| Australia | 3/27/20 | 0.24 | −35 | 2 | −30 | −53 | −26 | 17 | −30 |
1 Q3: The third interquartile.
Figure 1Correlation coefficients for all countries.
Figure 2Correlation coefficients for 13 countries during the period between 15 February 2020 and 11 April 2020.
Figure 3Correlation coefficients for 13 countries during the period between 15 February 2020 and 05 July 2020.